Determinants of early life immune responses to RSV infection

Current Opinion in Virology

Volumn 16, Issue , 2016, Pages 151-157

  Ruckwardt, Tracy J ^a   Morabito, Kaitlyn M ^a   Graham, Barney S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INNATE IMMUNITY; NEWBORN; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; VACCINATION; AGE; HOST PATHOGEN INTERACTION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; IMMUNOMODULATION; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

ADAPTIVE IMMUNITY; AGE FACTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFANT; INFANT, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84960871169     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2016.01.003     Document Type: Review

References (56)

1. C.B. Hall The burgeoning burden of respiratory syncytial virus among children Infect Disord Drug Targets 12 2012 92 97
2. H. Nair, D.J. Nokes, B.D. Gessner, M. Dherani, S.A. Madhi, R.J. Singleton, K.L. O'Brien, A. Roca, P.F. Wright, N. Bruce, and et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Lancet 375 2010 1545 1555
3. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S.Y. Ahn, and et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
4. L. Lambert, A.M. Sagfors, P.J. Openshaw, and F.J. Culley Immunity to RSV in early-life Front Immunol 5 2014 466
5. P.H. Burri Structural aspects of postnatal lung development - alveolar formation and growth Biol Neonate 89 2006 313 322
6. J. Stocks, A. Hislop, and S. Sonnappa Early lung development: lifelong effect on respiratory health and disease Lancet Respir Med 1 2013 728 742
7. D.J. Dowling, and O. Levy Ontogeny of early life immunity Trends Immunol 35 2014 299 310
8. F.P. Polack The changing landscape of respiratory syncytial virus Vaccine 33 2015 6473 6478
9. I. De Kleer, F. Willems, B. Lambrecht, and S. Goriely Ontogeny of myeloid cells Front Immunol 5 2014 423
10. E.R. Krow-Lucal, and J.M. McCune Distinct functional programs in fetal T and myeloid lineages Front Immunol 5 2014 314
11. A.L. Gervassi, and H. Horton Is infant immunity actively suppressed or immature? Virology (Auckl) 2014 2014 1 9
12. E.R. Krow-Lucal, C.C. Kim, T.D. Burt, and J.M. McCune Distinct functional programming of human fetal and adult monocytes Blood 123 2014 1897 1904
13. J.E. Mold, S. Venkatasubrahmanyam, T.D. Burt, J. Michaelsson, J.M. Rivera, S.A. Galkina, K. Weinberg, C.A. Stoddart, and J.M. McCune Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans Science 330 2010 1695 1699
14. M.A. Pettengill, S.D. van Haren, and O. Levy Soluble mediators regulating immunity in early life Front Immunol 5 2014 457
15. A.A. Luciano, I.M. Arbona-Ramirez, R. Ruiz, B.J. Llorens-Bonilla, D.G. Martinez-Lopez, N. Funderburg, and M.J. Dorsey Alterations in regulatory T cell subpopulations seen in preterm infants PLoS One 9 2014 e95867
16. J. Ndure, and K.L. Flanagan Targeting regulatory T cells to improve vaccine immunogenicity in early life Front Microbiol 5 2014 477
17. S. Elahi, J.M. Ertelt, J.M. Kinder, T.T. Jiang, X. Zhang, L. Xin, V. Chaturvedi, B.S. Strong, J.E. Qualls, K.A. Steinbrecher, and et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection Nature 504 2013 158 162
18. O. Levy, S. Goriely, and T.R. Kollmann Immune response to vaccine adjuvants during the first year of life Vaccine 31 2013 2500 2505
19. M.R. Ackermann Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments ILAR J 55 2014 4 15
20. M.S. Boukhvalova, and J.C. Blanco The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection Curr Top Microbiol Immunol 372 2013 347 358
21. P.J. Openshaw The mouse model of respiratory syncytial virus disease Curr Top Microbiol Immunol 372 2013 359 369
22. G. Taylor Bovine model of respiratory syncytial virus infection Curr Top Microbiol Immunol 372 2013 327 345
23. S.A. Cormier, D. You, and S. Honnegowda The use of a neonatal mouse model to study respiratory syncytial virus infections Expert Rev Anti Infect Ther 8 2010 1371 1380
24. S.A. Cormier, B. Shrestha, J. Saravia, G.I. Lee, L. Shen, J.P. DeVincenzo, Y.I. Kim, and D. You Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection J Virol 88 2014 9350 9360
25. N. Marr, T.I. Wang, S.H. Kam, Y.S. Hu, A.A. Sharma, A. Lam, J. Markowski, A. Solimano, P.M. Lavoie, and S.E. Turvey Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children J Immunol 192 2014 948 957
26. T.J. Ruckwardt, A.M. Malloy, K.M. Morabito, and B.S. Graham Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response PLoS Pathog 10 2014 e1003934
27. A.M. Malloy, A.R. Falsey, and T.J. Ruckwardt Consequences of immature and senescent immune responses for infection with respiratory syncytial virus Curr Top Microbiol Immunol 372 2013 211 231
28. S. Mukherjee, and N.W. Lukacs Innate immune responses to respiratory syncytial virus infection Curr Top Microbiol Immunol 372 2013 139 154
29. A. Iwasaki, and R. Medzhitov Control of adaptive immunity by the innate immune system Nat Immunol 16 2015 343 353
30. T.J. Ruckwardt, A.M. Malloy, E. Gostick, D.A. Price, P. Dash, J.L. McClaren, P.G. Thomas, and B.S. Graham Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice PLoS Pathog 7 2011 e1002377
31. M.V. Lukens, A.C. van de Pol, F.E. Coenjaerts, N.J. Jansen, V.M. Kamp, J.L. Kimpen, J.W. Rossen, L.H. Ulfman, C.E. Tacke, M.C. Viveen, and et al. A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants J Virol 84 2010 2374 2383
32. T.P. Welliver, R.P. Garofalo, Y. Hosakote, K.H. Hintz, L. Avendano, K. Sanchez, L. Velozo, H. Jafri, S. Chavez-Bueno, P.L. Ogra, and et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses J Infect Dis 195 2007 1126 1136
33. A.J. Stoppelenburg, S. de Roock, M.P. Hennus, L. Bont, and M. Boes Elevated Th17 response in infants undergoing respiratory viral infection Am J Pathol 184 2014 1274 1279
34. M.A. Alexander-Miller Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges J Immunol 193 2014 5363 5369
35. S. Basha, N. Surendran, and M. Pichichero Immune responses in neonates Expert Rev Clin Immunol 10 2014 1171 1184
36. C.J. Sande, P.A. Cane, and D.J. Nokes The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants Vaccine 32 2014 4726 4729
37. S.M. Varga, and T.J. Braciale The adaptive immune response to respiratory syncytial virus Curr Top Microbiol Immunol 372 2013 155 171
38. B.C. Holbrook, S.L. Hayward, L.K. Blevins, N. Kock, T. Aycock, G.D. Parks, and M.A. Alexander-Miller Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection Virology 476 2015 124 133
39. R.A. Karron, U.J. Buchholz, and P.L. Collins Live-attenuated respiratory syncytial virus vaccines Curr Top Microbiol Immunol 372 2013 259 284
40. T.G. Morrison, and E.E. Walsh Subunit and virus-like particle vaccine approaches for respiratory syncytial virus Curr Top Microbiol Immunol 372 2013 285 306
41. H.W. Kim, J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Chanock, K. Jensen, and R.H. Parrott Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine Am J Epidemiol 89 1969 422 434
42. J. Chin, R.L. Magoffin, L.A. Shearer, J.H. Schieble, and E.H. Lennette Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population Am J Epidemiol 89 1969 449 463
43. C.A. Siegrist Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants Vaccine 21 2003 3406 3412
44. J.S. McLellan, M. Chen, S. Leung, K.W. Graepel, X. Du, Y. Yang, T. Zhou, U. Baxa, E. Yasuda, T. Beaumont, and et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody Science 340 2013 1113 1117
45. J.S. McLellan, M. Chen, M.G. Joyce, M. Sastry, G.B. Stewart-Jones, Y. Yang, B. Zhang, L. Chen, S. Srivatsan, A. Zheng, and et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus Science 342 2013 592 598
46. D. Corti, S. Bianchi, F. Vanzetta, A. Minola, L. Perez, G. Agatic, B. Guarino, C. Silacci, J. Marcandalli, B.J. Marsland, and et al. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody Nature 501 2013 439 443
47. M.S. Gilman, S.M. Moin, V. Mas, M. Chen, N.K. Patel, K. Kramer, Q. Zhu, S.C. Kabeche, A. Kumar, C. Palomo, and et al. Characterization of a prefusion-specific antibody that recognizes a quaternary cleavage-dependent epitope on the RSV fusion glycoprotein PLoS Pathog 11 2015 e1005035
48. J.O. Ngwuta, M. Chen, K. Modjarrad, M.G. Joyce, M. Kanekiyo, A. Kumar, H.M. Yassine, S.M. Moin, A.M. Killikelly, G.-Y. Chuang, and et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera Sci Transl Med 2015 In press
49. B.S. Graham, K. Modjarrad, and J.S. McLellan Novel antigens for RSV vaccines Curr Opin Immunol 35 2015 30 38
50. S.C.T.P. Rts Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Lancet 386 2015 31 45
51. B.A. Heesters, R.C. Myers, and M.C. Carroll Follicular dendritic cells: dynamic antigen libraries Nat Rev Immunol 14 2014 495 504
52. F.M. Munoz Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis 28 2015 221 224
53. H.Y. Chu, M.C. Steinhoff, A. Magaret, K. Zaman, E. Roy, G. Langdon, M.A. Formica, E.E. Walsh, and J.A. Englund Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh J Infect Dis 210 2014 1582 1589
54. P.K. Munywoki, D.C. Koech, C.N. Agoti, N. Kibirige, J. Kipkoech, P.A. Cane, G.F. Medley, and D.J. Nokes Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding Epidemiol Infect 143 2015 804 812
55. P.K. Munywoki, D.C. Koech, C.N. Agoti, C. Lewa, P.A. Cane, G.F. Medley, and D.J. Nokes The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya J Infect Dis 209 2014 1685 1692
56. P. Poletti, S. Merler, M. Ajelli, P. Manfredi, P.K. Munywoki, D. Nokes, and A. Melegaro Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings BMC Med 13 2015 49